Radical transparency in post-market oversight of medicine safety
BMJ
.
2022 Oct 5:379:o2275.
doi: 10.1136/bmj.o2275.
Authors
Barbara Mintzes
1
,
Colleen Fuller
2
Affiliations
1
School of Pharmacy and Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia Barbara.mintzes@sydney.edu.au.
2
Independent Voices for Safe and Effective Drugs, Vancouver, BC, Canada.
PMID:
36198408
DOI:
10.1136/bmj.o2275
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Policy Making*